121 related articles for article (PubMed ID: 26467591)
1. Spatiotemporal evidence for cross-border spread of MDR-TB along the Trans-Siberian Railway line.
Gurjav U; Burneebaatar B; Narmandakh E; Tumenbayar O; Ochirbat B; Hill-Cawthorne GA; Marais BJ; Sintchenko V
Int J Tuberc Lung Dis; 2015 Nov; 19(11):1376-82. PubMed ID: 26467591
[TBL] [Abstract][Full Text] [Related]
2. Transmission of multi-drug resistant tuberculosis in Mongolia is driven by Beijing strains of Mycobacterium tuberculosis resistant to all first-line drugs.
Gurjav U; Erkhembayar B; Burneebaatar B; Narmandakh E; Tumenbayar O; Hill-Cawthorne GA; Marais BJ; Sintchenko V
Tuberculosis (Edinb); 2016 Dec; 101():49-53. PubMed ID: 27865397
[TBL] [Abstract][Full Text] [Related]
3. Multidrug-resistant tuberculosis in the Amazonas State, Brazil, 2000-2011.
Garrido Mda S; Bührer-Sékula S; Souza AB; de Oliveira GP; Antunes IA; Mendes JM; Saraceni V; Martinez-Espinosa FE; Ramasawmy R
Int J Tuberc Lung Dis; 2015 May; 19(5):531-6. PubMed ID: 25868020
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
[TBL] [Abstract][Full Text] [Related]
5. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea.
Choi JC; Lim SY; Suh GY; Chung MP; Kim H; Kwon OJ; Lee NY; Park YK; Bai GH; Koh WJ
J Korean Med Sci; 2007 Aug; 22(4):677-81. PubMed ID: 17728509
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
[TBL] [Abstract][Full Text] [Related]
8. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China.
Liang L; Wu Q; Gao L; Hao Y; Liu C; Xie Y; Sun H; Yan X; Li F; Li H; Fang H; Ning N; Cui Y; Han L
Thorax; 2012 Jul; 67(7):632-8. PubMed ID: 22403070
[TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007.
Bang D; Lillebaek T; Thomsen VØ; Andersen AB
Scand J Infect Dis; 2010 Apr; 42(4):288-93. PubMed ID: 20082573
[TBL] [Abstract][Full Text] [Related]
10. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
[TBL] [Abstract][Full Text] [Related]
11. A community-based TB drug susceptibility study in Mimika District, Papua Province, Indonesia.
Kelly PM; Ardian M; Waramori G; Anstey NM; Syahrial H; Tjitra E; Bastian I; Maguire GP; Lumb R
Int J Tuberc Lung Dis; 2006 Feb; 10(2):167-71. PubMed ID: 16499255
[TBL] [Abstract][Full Text] [Related]
12. Changing patterns and trends of multidrug-resistant tuberculosis at referral centre in Northern India: a 4-year experience.
Maurya AK; Singh AK; Kumar M; Umrao J; Kant S; Nag VL; Kushwaha RA; Dhole TN
Indian J Med Microbiol; 2013; 31(1):40-6. PubMed ID: 23508428
[TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with fluoroquinolone-resistant tuberculosis in a Beijing tuberculosis referral hospital.
Liu CH; Yang N; Wang Q; Hu YL; Li L; Zhang GY; Zhu B
Respirology; 2011 Aug; 16(6):918-25. PubMed ID: 21564401
[TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant tuberculosis in the Northern Territory: A 10-year retrospective case series.
Judge D; Krause V
Commun Dis Intell Q Rep; 2016 Sep; 40(3):E334-E339. PubMed ID: 28278406
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2008 and 2009. A report of the Australian Mycobacterium Reference Laboratory Network.
Lumb R; Bastion I; Carter R; Jelfs P; Keehner T; Sievers A
Commun Dis Intell Q Rep; 2011 Jun; 35(2):154-61. PubMed ID: 22010508
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant tuberculosis in New South Wales, Australia, 1999-2010: a case series report.
Roberts-Witteveen A; Reinten T; Christensen A; Sintchenko V; Seale P; Lowbridge C
Int J Tuberc Lung Dis; 2015 Jul; 19(7):850-6. PubMed ID: 26056113
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity Pattern of Second Line Anti-Tuberculosis Drugs against Clinical Isolates of Multidrug Resistant Mycobacterium tuberculosis.
Ghafoor T; Ikram A; Abbasi SA; Zaman G; Ayyub M; Palomino JC; Vandamme P; Martin A
J Coll Physicians Surg Pak; 2015 Apr; 25(4):250-3. PubMed ID: 25899188
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011.
Kapata N; Chanda-Kapata P; Bates M; Mwaba P; Cobelens F; Grobusch MP; Zumla A
Trop Med Int Health; 2013 Nov; 18(11):1386-91. PubMed ID: 24033538
[TBL] [Abstract][Full Text] [Related]
20. Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India.
Kumar P; Kumar P; Balooni V; Singh S
Int J Tuberc Lung Dis; 2015 Apr; 19(4):434-9. PubMed ID: 25859999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
